Sagimet Biosciences Inc Series A Common Stock
Price & Volume
Stats
See more52W Range | $2.39-$20.71 |
Market Cap | $191.2M |
Shares Short | 4M |
Financials
See moreRevenue (12 Mos) | $2M |
Revenue Growth (YoY) | 0% |
Gross Profit (12 Mos) | $0 |
Diluted EPS | -$0.92 |
News
See moreYahoo Finance • 7 months ago
What's Going On With Fattly Liver Disease Focused Madrigal Pharmaceuticals, Sagimet Biosciences Shares On Wednesday?
Yahoo Finance • last year
Sagimet Biosciences Announces Acceptance of Two Abstracts at AASLD - The Liver Meeting® 2023
Yahoo Finance • last year
Sagimet Biosciences To Present at the H.C. Wainwright 7th Annual NASH Investor Conference
About
CEO | Mr. David A. Happel |
CFO | Mr. Thierry Chauche |
Address | 155 Bovet Road, San Mateo, CA, United States, 94402 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 8 |
